Update on human African trypanosomiasis (sleeping sickness)

被引:64
|
作者
Kennedy, Peter G. E. [1 ]
机构
[1] Univ Glasgow, Inst Infect Immun & Inflammat, Coll Med Vet & Life Sci, Garscube Campus, Glasgow G61 1QH, Lanark, Scotland
关键词
Human African trypanosomiasis; Sleeping sickness; Tsetse fly; Diagnostic staging; CNS; Parasite; Sub-Saharan Africa; BRUCEI-GAMBIENSE TRYPANOSOMIASIS; MULTICENTER; ISSUES; CNS;
D O I
10.1007/s00415-019-09425-7
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Human African trypanosomiasis (HAT), also known as sleeping sickness, is one of the Africa's 'neglected diseases' and is caused by infection with protozoan parasites of the Trypanosoma genus. Transmitted by the bite of the tsetse fly, it puts 70 million people at risk throughout sub-Saharan Africa and is usually fatal if untreated or inadequately treated. In this brief overview, some important recent developments in this disease are outlined. These cover various aspects including a reduction in disease incidence, newly recognised parasite reservoir sites in humans, disease outcome, novel diagnostic methods, new and improved treatment, and disease neuropathogenesis.
引用
收藏
页码:2334 / 2337
页数:4
相关论文
共 50 条
  • [1] Update on human African trypanosomiasis (sleeping sickness)
    Peter G. E. Kennedy
    [J]. Journal of Neurology, 2019, 266 : 2334 - 2337
  • [2] The continuing problem of human African trypanosomiasis (Sleeping sickness)
    Kennedy, Peter G. E.
    [J]. ANNALS OF NEUROLOGY, 2008, 64 (02) : 116 - 126
  • [3] Sleeping hearts: the role of the heart in sleeping sickness (human African trypanosomiasis)
    Blum, Johannes A.
    Burri, Christian
    Hatz, Christoph
    Kazumba, Leon
    Mangoni, Patrick
    Zellweger, Michael J.
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2007, 12 (12) : 1422 - 1432
  • [4] History of sleeping sickness (African trypanosomiasis)
    Cox, FEG
    [J]. INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2004, 18 (02) : 231 - +
  • [5] DRUGS USED IN THE TREATMENT OF SLEEPING SICKNESS (HUMAN AFRICAN TRYPANOSOMIASIS - HAT)
    WERY, M
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1994, 4 (03) : 227 - 238
  • [6] FDG PET/CT in a Case of Human African Trypanosomiasis (Sleeping Sickness)
    Xiao, Zhengguang
    Dong, Aisheng
    Wang, Yang
    [J]. CLINICAL NUCLEAR MEDICINE, 2018, 43 (08) : 619 - 622
  • [7] Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)
    Kennedy, Peter G. E.
    [J]. LANCET NEUROLOGY, 2013, 12 (02): : 186 - 194
  • [9] EXPANDING BELT OF HUMAN AFRICAN TRYPANOSOMIASIS (SLEEPING SICKNESS) IN PALLISA DISTRICT, UGANDA
    Okedi, Loyce
    Patrick, A.
    Alioni, V.
    Azabo, R.
    Sebikali, C.
    Okitoi, M.
    Amusugut, T.
    Nalapa, M.
    Mugyenyi, A.
    Kakembo, A.
    Enyaru, J. C. K.
    Aksoy, S.
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2009, 81 (05): : 138 - 139
  • [10] Sleeping glands? -: The role of endocrine disorders in sleeping sickness (Tb. gambiense human African trypanosomiasis)
    Blum, Johannes A.
    Schmid, Caecilia
    Hatz, Christoph
    Kazumba, Leon
    Mangoni, Patrick
    Rutishauser, Jonas
    la Torre, Anna
    Burri, Christian
    [J]. ACTA TROPICA, 2007, 104 (01) : 16 - 24